FindTrial
Sign In

Cancelled by the investigator. A prospective cohort study of non-alcoholic fatty liver disease (NAFLD) after liver hepatectomy effects on non-Alzheimer’s patients’ Dementia risks in NCCN guidelines for patient high-risk liver cancer disease analysis.

A prospective cohort study of non-alcoholic fatty liver disease (NAFLD) after liver hepatectomy effects on Non-Alzheimer’s patients’ Dementia risks in NCCN guidelines for patient high-risk liver cancer disease analysis. - Hepatectomy Surgery for Non-Alzheimer’s cancer patients increased dementia risk: A prospective cohort study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099936
Enrollment
Unknown
Registered
2025-04-01
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Interventions

Intervention group:NCCN Guidelines for Hepatocellular Carcinoma Patients
Intervention group:Non-alcoholic fatty liver disease
Intervention group:Non-Alzheimer’s dementia patient
Intervention group:Liver Partial Hepatectomy
Intervention group:Dementia patient

Sponsors

Shaoguan University Faculty of Science and Technology, Graduate School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. NCCN Liver Cancer Disease Guidelines High and Low Risk Scores; 2. Non alcoholic fatty liver disease (NAFLD); 3. Non Alzheimer's patients with dementia; 4. Liver resection surgery; 5. Risk of developing dementia; 6. Very high risk; 7. High risk.

Exclusion criteria

Exclusion criteria: 1. Hepatitis B; 2. Hepatitis C; 3. Non alcoholic fatty liver disease; 4. Hypertension; 5. Obesity; 6. Hypertension; 7. Diabetes; 8. Kidney disease; 9. Vascular dementia; 10. Huntington's dementia; 11. Parkinson's dementia; 12. Depression; 13. Anxiety; 14. Paraplegia; 15. Delirium.

Design outcomes

Primary

MeasureTime frame
Dementia;NCCN Guidelines for Hepatocellular Carcinoma Patients’ version 2020 to 2024 (n=300);—

Secondary

MeasureTime frame
Liver Partial Hepatectomy ;Non-Alzheimer’s dementia patient ;Non-alcoholic fatty liver disease ;—

Countries

China

Contacts

Public ContactJiaping Wu

Department of Medical Technology, Shaoguan University

wu20227050@163.com+86 751 812 1423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026